Fortis Healthcare Sees Sharp Open Interest Surge Amid Prolonged Downtrend

Open Interest and Volume Dynamics

On 30 Sep 2026, Fortis Healthcare’s open interest (OI) in derivatives jumped sharply by 6,305 contracts, a 32.57% increase from the previous day’s 19,358 to 25,663. This surge in OI was accompanied by a substantial volume of 40,460 contracts traded, indicating robust participation from market participants. The futures value stood at ₹23,408.56 lakhs, while the options segment exhibited an enormous notional value of approximately ₹22,854.38 crores, culminating in a total derivatives value of ₹28,192.50 lakhs.

This spike in open interest, particularly amid a falling stock price, often suggests that new positions are being initiated rather than existing ones being squared off. The increase in OI alongside high volume points to fresh directional bets, with traders possibly anticipating further downside or hedging existing exposures.

Price Action and Market Sentiment

Fortis Healthcare’s underlying share price closed at ₹766, hitting a new 52-week low of ₹760.5 during intraday trading. The stock underperformed its sector, the Hospital & Healthcare Services, which itself declined by 4.58%, while Fortis fell by 6.62% on the day. Over the past six consecutive sessions, the stock has lost 15.06%, reflecting sustained selling pressure.

Notably, the stock opened with a gap down of 7.48%, trading within a narrow intraday range of just ₹1.25, with the weighted average price skewed towards the day’s low. This price behaviour, coupled with an intraday volatility of 5.33%, underscores heightened uncertainty and bearish sentiment among investors.

Technical Indicators and Moving Averages

Technically, Fortis Healthcare is trading below all major moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a clear downtrend. The stock’s inability to reclaim these key technical levels suggests that bears remain firmly in control, and any short-term rallies may face resistance.

Investor participation has also risen sharply, with delivery volumes on 29 Sep reaching 16.94 lakh shares, a 92.86% increase over the five-day average. This surge in delivery volume indicates that long-term investors are either exiting positions or repositioning amid the ongoing weakness.

Market Positioning and Potential Directional Bets

The sharp increase in open interest amid falling prices suggests that traders are either initiating fresh short positions or buying protective puts to hedge existing long exposures. The large notional value in options indicates active participation in both calls and puts, but given the stock’s downtrend and new lows, bearish bets appear to dominate.

Moreover, the hospital sector’s underperformance relative to broader indices like the Sensex, which declined only 0.42% on the same day, highlights sector-specific headwinds. These may include concerns over regulatory changes, rising costs, or subdued patient volumes impacting Fortis Healthcare’s near-term outlook.

Fortis’s Mojo Score currently stands at 44.0, with a Mojo Grade downgraded from Hold to Sell as of 15 Sep 2026. This downgrade reflects deteriorating fundamentals and technical weakness, reinforcing the cautious stance among investors and analysts alike. The company’s mid-cap market capitalisation of ₹58,853 crores places it in a segment where volatility can be pronounced, especially amid sectoral pressures.

Liquidity and Trading Considerations

Liquidity remains adequate for Fortis Healthcare, with the stock’s traded value supporting a trade size of approximately ₹3.35 crores based on 2% of the five-day average traded value. This ensures that institutional and retail investors can execute sizeable trades without significant market impact, which may further fuel volatility as positions are adjusted.

Given the stock’s current technical and fundamental challenges, investors should exercise caution. The persistent downtrend, combined with rising open interest, suggests that the market consensus is skewed towards further weakness or at best, a prolonged consolidation phase.

Outlook and Investor Takeaways

Fortis Healthcare’s recent derivatives activity and price action paint a cautious picture for investors. The surge in open interest amid a six-day losing streak and new 52-week lows signals that market participants are positioning for continued downside or volatility. The downgrade to a Sell grade by MarketsMOJO further emphasises the need for prudence.

Investors should closely monitor upcoming sector developments, quarterly earnings, and regulatory announcements that could influence Fortis’s trajectory. Those holding long positions may consider hedging strategies, while traders might look for confirmation of trend reversals before initiating fresh longs.

In summary, the combination of technical weakness, increased open interest, and sectoral headwinds suggests that Fortis Healthcare remains under pressure in the near term. Market participants are advised to weigh risks carefully and consider alternative investment opportunities within the hospital sector or broader healthcare space.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today